Sanofi-Aventis S.A. ADR (SNY)

Even a vaccine that's 50% effective with some side effects would be a game changer. The Trump Administration is throwing billions into that hope and investors are seeing big profits.

Once Slow, Stable Sanofi Stock is Now Pharma’s Most-Talked About Name

By Dana Blankenhorn, InvestorPlace Contributor Aug 19, 2020

SNY stock is no longer a sleepy passive investment. Under a new CEO, Sanofi is less reliant on diabetes and heart drugs and looking to buy pre-market cancer blockbusters.

5 Biotech Stocks That Offer Long-Term Growth and Value

By Faizan Farooque, InvestorPlace Contributor Aug 6, 2020

Biotech stocks are on fire at the moment. That said, here are five names from the sector that offer long-term value and strong fundamentals.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

New Sanofi CEO 2019: 8 Things to Know About Paul Hudson

By William White, InvestorPlace Writer Jun 7, 2019

There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.

Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss

By William White, InvestorPlace Writer May 7, 2019

Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period.

3 Biotech Stocks That Pay Solid Dividends

By Chris Lau, InvestorPlace Contributor Feb 5, 2019

Biotech stocks offer more than just capital gains; some of them pay dividends. Here are three dividend-paying biotechs to consider.

7 Major Pharmaceutical Stocks to Quarantine Now

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2018

Despite their indispensable demand, pharmaceutical stocks face tough roadblocks as competition for breakthrough drugs intensifies.

5 Biotech Stocks to Scoop Up for Big Dividends

By Aaron Levitt, InvestorPlace Contributor Nov 27, 2018

Biotech stocks can still pay you some big yields. Here are five of the best dividend stocks in the pharma sector.

6 Pharmaceutical Stocks to Buy After the Midterms

By Chris Lau, InvestorPlace Contributor Nov 9, 2018

The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.

Why Sanofi Stock Should Run Higher Despite Mixed Earnings

By Will Healy, InvestorPlace Contributor Jul 31, 2018

SNY stock beat on earnings and missed on revenue, but sales of newer drugs as well as a low P/E and a high dividend show promise for Sanofi.

5 Pharmaceutical and Biotech Stocks to Consider for July

By Chris Lau, InvestorPlace Contributor Jul 6, 2018

Pfizer renewed the drug price hike cycle after it raised them for around 40 products. If other biotech stocks follow, profits will soar.

Sanofi SA Shares Slip on Falling Sales

By William White, InvestorPlace Writer Apr 27, 2018

Sanofi (SNY) stock was down Friday after the company released disappointing sales for its first-quarter 2018 earnings report.

10 Stocks to Ride Out the Market Storm

By James Brumley, InvestorPlace Feature Writer Feb 6, 2018

Put these tickers on a list of stocks to buy here in the midst of market-wide carnage. They're likely to recover first and best once the selloff settles.

Biotech M&A: Sanofi SA (ADR) Inks 2nd Multi-Billion Dollar Deal in a Week

By InvestorPlace Staff Jan 29, 2018

Sanofi (SNY) inks second multi-dollar deal this month. Since the earlier deal last Monday, SNY stock gained 2.6% in a week.

Sanofi-Aventis S.A. ADR (SNY)

7 Cheap Value Stocks to Buy for August 2021

15 European Dividend Aristocrats to Diversify Your Portfolio

7 Best Vaccine Stocks for Their Pipeline Potential

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Sanofi-Aventis S.A. ADR (SNY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News

Subscriber Sign in